Małgorzata J. J.
- Country
- Poland
- Department
- Dermatology Department
Research Overview
- Efficacy and Safety Evaluation of JNJ-77242113 Versus Placebo and Deucravacitinib in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Controlled Trial
- Efficacy and Safety Evaluation of JNJ-77242113 in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
- Efficacy and Safety Evaluation of JNJ-77242113 in Moderate to Severe Plaque Psoriasis Affecting Special Areas: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 161 of 353 partner sites.
Specializations
Inflammatory Arthritis and Spondyloarthritis
Clinical activity is centered on psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, and non-radiographic axial spondyloarthritis, with additional involvement in broader immune-mediated musculoskeletal disease.
- Psoriatic arthritis
- Rheumatoid arthritis
- Axial spondyloarthritis
- Non-radiographic axial spondyloarthritis
- Active psoriatic arthritis
The therapeutic focus includes agents directed at joint inflammation, symptom control, and preservation of function in chronic inflammatory rheumatic disorders.
Psoriasis and Immune-Mediated Skin Disease
Research involvement extends to plaque psoriasis, genital psoriasis, and related psoriatic disease manifestations, reflecting a strong interest in dermatologic immune-targeted therapy.
- Moderate-to-severe plaque psoriasis
- Genital psoriasis
- Psoriatic arthritis with skin involvement
- Plaque psoriasis
- Moderate to severe psoriasis
This area includes evaluation of treatments aimed at reducing cutaneous inflammation, improving skin clearance, and addressing difficult-to-treat psoriasis subtypes.
Alopecia Areata and Dermatologic Autoimmunity
The investigator is also involved in studies of severe alopecia areata, supporting therapeutic development in autoimmune hair loss and related dermatology-focused immunomodulation.
- Severe alopecia areata
- Adult and adolescent alopecia areata
- Autoimmune hair loss
Clinical interest in this domain is directed toward treatments that target immune-driven follicular damage and restoration of hair growth.
Metabolic Disease and Cardiometabolic Risk
Another major area of involvement includes type 2 diabetes, obesity, overweight, and severe hypertriglyceridemia, alongside studies addressing glycaemic control and related metabolic complications.
- Type 2 diabetes
- Obesity
- Overweight
- Severe hypertriglyceridemia
- Cardiovascular disease
The therapeutic landscape also includes management of weight-related disease and metabolic risk in patients with overlapping inflammatory and endocrine conditions.
Musculoskeletal Pain and Bone Health
Clinical work further spans chronic pain due to knee osteoarthritis, diabetic peripheral neuropathy, and osteoporosis, with attention to pain relief and skeletal protection.
- Chronic knee osteoarthritis pain
- Diabetic peripheral neuropathic pain
- Osteoporosis
- Overweight and knee osteoarthritis
This area reflects therapeutic interest in conditions where pain, mobility, and bone integrity are central clinical concerns.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.